Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
10/01/08
Horizon Therapeutics to Present at JMP Securities Healthcare Focus ConferenceSKOKIE, Ill. , October 1, 2008 - Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that Timothy P. Walbert, president and chief executive officer, will present a corporate overview at the JMP Securities Healthcare Focus Conference in New York on Tuesday, October 7 at 9 a.m. ET at the Le Parker Meridien Hotel.
About Horizon Therapeutics
Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit www.horizontherapeutics.com.
Contact:
Geoff Curtis
WeissComm Partners, Inc.
312-284-4701
gcurtis@wcpglobal.com